Eric Dobmeier, Founder of Chinook Therapeutics

Eric Dobmeier is the founder of Chinook Therapeutics. Chinook Therapeutics has raised $65M in total funding. Latest round: Series A.

About Eric Dobmeier

Eric Dobmeier is the President and CEO of Chinook Therapeutics, a clinical-stage biopharmaceutical company focused on precision medicines for rare, severe chronic kidney diseases. He led the company through strategic growth initiatives that resulted in its acquisition by Novartis in 2023 for up to $3.5 billion. Prior to and following his CEO role, he has served as a Venture Partner at Samsara BioCapital and conducted board and advisory work.

Eric Dobmeier at a glance

More founders in Vancouver, British Columbia, Canada (44)

Browse related founder lists (5)

Full founder directory · Investor directory · Company funding database · Fundraising library